Therapeutic Advances in Psychopharmacology

Therapeutic Advances in Psychopharmacology is a gold open access journal published by SAGE with a clinical and pharmacological focus, launched in 2011, with a 2025 Journal Impact Factor of 5.0.《精神药理学治疗进展》（Therapeutic Advances in Psychopharmacology）由（SAGE）出版，2011 年创刊，为金色开放获取期刊，侧重临床与药理学，2025 年期刊影响因子为 5.0。

Scope

• The journal is a peer-reviewed open access title with a strong clinical and pharmacological focus.刊物是同行评审的开放获取期刊，具有鲜明的临床与药理学取向。
• It is aimed at clinicians and researchers in psychopharmacology.读者对象为精神药理学领域的临床医师与研究人员。
• It publishes research articles, reviews and scholarly comment on pioneering efforts and innovative studies across psychopharmacology.刊物发表精神药理学各方向开拓性努力与创新研究的论文、综述与学术评论。
• Content covers all areas of psychopharmacology, from drug mechanisms to clinical management.内容覆盖精神药理学的全部领域，从药物机制到临床管理。
• All articles are made freely available online immediately upon publication.所有文章在发表后立即在线免费开放。
• Special collections assemble reviews and research on topics such as lithium in mood disorders and clozapine in older adults.专门合集汇集关于锂盐用于心境障碍、氯氮平用于老年患者等主题的综述与研究。

History

• Therapeutic Advances in Psychopharmacology was launched in 2011.《精神药理学治疗进展》创刊于 2011 年。
• It belongs to SAGE's Therapeutic Advances series of clinical journals, which began in 2008 and now numbers around twenty titles.刊物属于（SAGE）「治疗进展」临床期刊系列，该系列始于 2008 年，现有约二十种刊物。
• It is a gold open access journal, though it began publishing fully in open access in 2019.刊物为金色开放获取期刊，自 2019 年起全面以开放获取形式出版。
• The journal is listed in PubMed and indexed in Web of Science and Science Citation Index Expanded.刊物被 PubMed 收录，并被科学网与科学引文索引扩展版索引。
• Its 2025 Journal Impact Factor is 5.0, after 4.0 in 2024, 4.988 in 2022 and 5.0 in 2021, with a five-year impact factor of 4.5.2025 年期刊影响因子为 5.0，此前 2024 年为 4.0，2022 年为 4.988，2021 年为 5.0，其五年影响因子为 4.5。
• The journal receives more than one million full-text article views annually.刊物每年全文阅读量超过一百万次。
• Articles are published under CC BY or CC BY-NC licences, and the article processing charge is about 2,650 US dollars.文章在 CC BY 或 CC BY-NC 许可下发表，文章处理费约为 2,650 美元。

Editors

• The Editor-in-Chief is David Taylor, professor at the Maudsley Hospital and King's College London.主编为（David Taylor），莫兹利医院与伦敦国王学院教授。
• Managing editors are based at SAGE in London and India and coordinate the journal's editorial process.执行编辑分别任职于（SAGE）伦敦与印度办公室，协调刊物的编辑流程。
• Associate editors include Mark Horowitz of University College London and the North East London NHS Trust.副主编包括伦敦大学学院与东北伦敦国民健康服务体系信托的（Mark Horowitz）。
• James Rucker of King's College London and Shuichi Suetani of the Queensland Centre for Mental Health Research also serve as associate editors.伦敦国王学院的（James Rucker）与昆士兰心理健康研究中心的（Shuichi Suetani）同样担任副主编。
• Balwinder Singh of the Mayo Clinic is associate editor for special collections.梅奥诊所的（Balwinder Singh）担任专门合集方向的副主编。
• Peer review is anonymous, and the journal checks submissions for plagiarism.刊物采用匿名同行评审，并对投稿进行查重检查。